Clinical Trial: Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07212426) titled 'Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.' on Sept. 30.

Brief Summary: This is a multicenter, randomized, open-label, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-005 injection in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

Study Start Date: Nov. 14, 2024

Study Type: INTERVENTIONAL

Condition: PNH - Paroxysmal Nocturnal Hemoglobinuria

Intervention: DRUG: Biological/Vaccine: LP-005

Participants were administered LP-005 as an IV infusion every 4 weeks.

DRUG: Biological/Vaccine: LP-005

Participants were administered LP-005 as an IV infus...